Adverse events for albiglutide versus lispro included severe hypoglycemia ( 0 vs. 2 events ) , documented symptomatic hypoglycemia ( 15.8 % vs. 29.9 % ) , nausea ( 11.2 % vs. 1.4 % ) , vomiting ( 6.7 % vs. 1.4 % ) , and injection site reactions ( 9.5 % vs. 5.3 % ) .